期刊文献+

从药物临床试验数据核查看研究者的职责履行情况 被引量:38

Perspectives on the performing of investigators’ responsibilities from drug clinical trial data inspection
原文传递
导出
摘要 在药物临床试验中,研究者作为实施者、临床试验质量及受试者安全权益的直接责任人,发挥着关键作用。本文根据《药物临床试验质量管理规范》(good clinical practice,GCP)的相关规定及药物临床试验监督检查新形势下对研究者的职责要求,结合药物临床试验数据核查中研究者存在的常见问题,对研究者在临床试验中应履行的职责进行分析和探讨。 Investigators,who serve as the implementers of drug clinical trials,the persons directly responsible for the quality of drug clinical trials as well as the safety and rights of subjects,play a critical role in drug clinical trials.In accordance with the good clinical practice(GCP)and the requirements for investigators under the new situation of drug clinical trial supervision,this paper analyzed and discussed the responsibilities of investigators in drug clinical trials,combined with the common findings related to investigators during the clinical trial data inspection.
作者 高荣 吕术超 李秀丽 雷明武 钱雪 GAO Rong;LU Shu-chao;LI Xiu-li;LEI Ming-wu;QIAN Xue(Center for Food and Drug Inspection,National Medical Products Administration.Beijing 100044,China)
出处 《中国新药杂志》 CAS CSCD 北大核心 2019年第20期2508-2512,共5页 Chinese Journal of New Drugs
关键词 药物临床试验 药物临床试验质量管理规范 数据核查 研究者 职责 drug clinical trials good clinical practice data inspection investigator responsibilities
  • 相关文献

参考文献1

二级参考文献2

共引文献20

同被引文献306

引证文献38

二级引证文献115

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部